What is LUNG (LUNG) stock price today?

LUNG (LUNG) is currently trading at $2.28, up 1.79% today.

What is LUNG P/E ratio?

LUNG's P/E ratio is -1.23. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LUNG return on equity (ROE)?

LUNG's return on equity (ROE) is -86.22%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is LUNG's market cap?

LUNG has a market capitalization of $96.30M.

NASDAQ · Medical - Devices

LUNG (LUNG) Stock

$2.28 +1.79% NASDAQ: LUNG Healthcare

Valuation

Metric	Value
Price	$2.28
Market Cap	$96.30M
P/E Ratio	-1.23
P/B Ratio	1.18
P/S Ratio	0.61
EPS (TTM)	$-1.05
52-Week High	$3.88
52-Week Low	$1.13
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-86.22%
ROA	-24.04%
ROCE	-100.00%
Gross Margin	75.49%
Operating Margin	-58.79%
Net Margin	-60.09%
Debt/Equity	1.23
Current Ratio	5.10

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$48.0M	$54.0M	$69.0M	$84.0M	$90.0M
Operating Profit	$-47.0M	$-59.0M	$-62.0M	$-58.0M	$-54.0M
Net Profit	$-49.0M	$-59.0M	$-61.0M	$-56.0M	$-54.0M
EPS	$-1.35	$-1.59	$-1.60	$-1.44	$-1.33
Op Margin	-97.7%	-109.3%	-90.2%	-68.9%	-59.3%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$235.0M	$194.0M	$178.0M	$163.0M	$129.0M
Total Liabilities	$42.0M	$40.0M	$59.0M	$77.0M	$75.0M
Cash	$148.0M	$102.0M	$84.0M	$71.0M	$70.0M
Borrowings	$26.0M	$24.0M	$41.0M	$56.0M	$56.0M

Latest News

Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire · Jul 15, 2026 Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 1, 2026 Pulmonx (LUNG) Q1 2026 Earnings Transcript Motley Fool · Apr 30, 2026 Pulmonx Corporation Q1 2026 Earnings Call Summary Moby · Apr 30, 2026 Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... GuruFocus.com · Apr 30, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-41.0M	$-45.0M	$-38.0M	$-32.0M	$-32.0M
Investing Cash Flow	$-50.0M	$-6.0M	$-3.0M	$16.0M	$30.0M
Financing Cash Flow	$0	$0	$1.0M	$1.0M	$0
Net Cash Flow	$-83.0M	$-47.0M	$-18.0M	$-13.0M	$-1.0M
Free Cash Flow	$-45.0M	$-46.0M	$-38.0M	$-33.0M	$-33.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-28.92
EV / EBITDA	-0.95
FCF Yield	-54.49%
Quick Ratio	4.04
Interest Coverage	-18.00
Return 1Y	-46.30%
Return 3Y	-89.24%
Return 5Y	-96.16%

Ownership

Insiders Held4.89%

Institutions Held78.83%

Institutions Float Held82.88%

Institutional Holder	Shares	Report Date
Primecap Management Company	4,724,991	2026-03-31
Morgan Stanley	3,993,562	2026-03-31
Soleus Capital Management, L.P.	2,788,323	2026-03-31
Blackrock Inc.	2,661,607	2026-03-31
ExodusPoint Capital Management, LP	1,943,834	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACRV	$2.15	+3.86%	-1.10	$92.02M	0.00%
ASRT	$23.44	+0.30%	-4.95	$151.47M	0.00%
EDAPEdap Tms S.a.	$4.76	-0.52%	-6.63	$178.23M	0.00%
HYPR	$0.81	-0.58%	-3.44	$67.88M	0.00%
IMUX	$14.24	-2.33%	-2.97	$193.97M	0.00%

About LUNG

LUNG is led by CEO Glendon E. French, employs 291 people, headquartered in US, publicly traded since 2020.

LUNG stock trades at $2.28 with a market capitalization of $96.30M. The stock is valued at a price-to-earnings (P/E) ratio of -1.23, price-to-book of 1.18, price-to-sales of 0.61. Over the past 52 weeks the stock has ranged between $1.13 and $3.88, and currently trades 41.2% below its 52-week high.

On profitability, LUNG generates a return on equity (ROE) of -86.22%, return on capital employed of -100.00%, an operating margin of -58.79%, a net profit margin of -60.09%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides